Tech Company Financing Transactions
Anagenex Funding Round
Anagenex, operating out of Woburn, secured $30 million in investment from Catalio Capital Management, Air Street Capital and Khosla Ventures.
Transaction Overview
Company Name
Announced On
6/8/2022
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series A
Investors
Catalio Capital Management (Lead Investor) (George Petrocheilos)
Lux Capital (Zavain Dar)
Proceeds Purpose
Anagenex will use its Series A funds to further expand its novel data generating platform and build a robust pipeline of programs addressing historically challenging unmet medical needs.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10 Roessler Rd. Unit N
Woburn, MA 01801
USA
Woburn, MA 01801
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
We are building a directed evolution platform to develop new small molecules by combining massively parallel biochemical experiments and machine learning. A fully integrated team of experts in biology, chemistry and machine learning working as one to find new medicines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nicolas Tilmans
Vice President
Svetlana Belyanskaya
Vice President
Joe Franklin
Vice President
Henri Palacci
Browse more venture capital transactions:
Prev: 6/8/2022: Curio venture capital transaction
Next: 6/8/2022: CareAcademy venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs